Member Info for Valuefinder

Agree with oldbaldy. Good problem to have that. Sell at 300% or 400% up...:)

Also, apologies for my atrocious spelling. Bloody iPhone and autocorrect

I don’t need sell anybody on the day of RNS. Past history tells me that normally you get pretty good rises subsequent to RNS day, which from memory in some my multibaggers (long time ago) double my profit on second/third day. So I usually sell some a few days later, but all depends on the news flow

*gold bar

Mathsprof- one can find negatives even in shinny hold bar, if they want to bargain for a lower price. You seem to kind of trying your hardest to come up with questions or points which merely attempt to throw doubt. What is your concern exactly, apart from coming up with pointless points around RNS’s from 2years ago? And yes, it would be awesome to have 1000 people to test, but 1. That’s not the norm for you his stage and 2. Costs money, which a small company like this doesn’t have. If you want this kind of scenario, invest in GSK pls
The unknown?

Oil-Beast - no, I have not done any research on 4D as am not invested. However, I believe I am factually correct. "Similar news, with 12 patients, added £60m to their mkt cap". I appreciate it that they have a deal with Merck but the increase in SP was purely based on the success of the trial, rather than the deal with Merck? Anyway, I don't want to bang on about it, don't know enough to debate, but the RNS from 4D seemed a pretty straight forward comparison from number of patients and the clinical phase perspective

Stach - interesting how similar news sent DDDD £60m higher, on just 12 patients. I appreciate it that you're concerned for us, but I don't think we need it.

I love the way people come here, not having read the info properly, say we are right on cash. I said earlier, and Mer400 challenges it, but we will have approx £3m of cash if all warrants are exercised. If you add all placenta done, plus warrants plus tax rebates, it’s jot far off £3m. Considering their admin expenses are not more than £300k per year, there is plenty of cash in the bank. If warrants don’t get exercised, then I’m happy for Val to raise funds at 50p. In fact, I’ll be delighted if they did that and warrants expire.

30 to buy now. Excellent day and quite high volume still. Val 201 could be a company maker

Let's hope this time the 28p is broken for good. This has been a little barrier for Val, so breaking it should see us above 30p soon. BANG

wow, it's quiet here today...

Trying to break the recent intraday high of 28p. Once broken, I see this moving up quite a bit more.

28.25 to sell now. Doing absolutely fantastic already. We will hopefully end the week in mid 30s. Every day we don't get those results, it's another day to build on the re-rate of this.

Exactly Mer, with about £3m in cash (once all warrants are exercised), and only £300k of expenses per annum, there is need for placing for a long time. We won’t need it anyway if a large Pharma comes onboard

We should have an incredibly interesting couple of weeks here. Over £1 by be end of September anyone? :)

We still await the val 201 results. Come on Val, tell us what’s happening with 201. Let’s hope we have a great week here.

Grace - that made me chuckle so much :). Night all, and Baxter.....if you can't handle the drink, stay away from it. And don't insult our Grace pls

Grace - good to be cautious. There is no investment without risk, the higher the risk the higher the reward... Although here is risk is much reduced, but the reward is significant due to the starting point of Val. The old management did a good job of scr**ing this company over, so now with Suzi in charge, this needs to re-rate in line with peers before the news gives it Hopefully) a massive boost. If they get 4/5 of the 8 to have a reduced PSA, then I think I will have a big smile on my face, both from a financial perspective and from a health perspective (I am sure e all know someone who's suffered from this horrible disease).

GL all

Jambo - your maths is way off. 1.45m more like it

Thymers - you sold nearly 1.5m shares (approx £180k) for a gain of 26k shares (£3.5k ish?). It’s amazing how you call that a good strategy....if you’d gained 10% of your holding, it might make some sense, but for 25k shares? Strange!

Tom - NO!

So, £14m market cap, circa £3m cash in the bank with only £300k per annum admin costs, a range of RNSs expected in the next few weeks/months, with the next and quite important RNS on Val 201 expected in the next few days or couple of weeks which could make this company exceed £50m, and which would only bring Val in line to other peers. Exciting couple of weeks or so coming up